Investor mix
5 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Private equity | 2 | 40% |
| Other / undisclosed | 1 | 20% |
Developer of therapies for rare diseases like Haemophilia, Inflammation, and Genetic diseases
5 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Private equity | 2 | 40% |
| Other / undisclosed | 1 | 20% |